Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
Emerging issues related to COVID-19 vaccination in patients with cancer / K.S. Saini, D. Martins-Branco, M. Tagliamento, L. Vidal, N. Singh, K. Punie, M.L. Saini, I. Chico, G. Curigliano, E. de Azambuja, M. Lambertini. - In: ONCOLOGY AND THERAPY. - ISSN 2366-1070. - (2021). [Epub ahead of print] [10.1007/s40487-021-00157-1]
Titolo: | Emerging issues related to COVID-19 vaccination in patients with cancer | |
Autori: | ||
Parole Chiave: | Cancer; COVID-19; Efficacy; mRNA; SARS-CoV-2; Toxicity; Vaccine; Viral vector | |
Settore Scientifico Disciplinare: | Settore MED/06 - Oncologia Medica | |
Data di pubblicazione: | 2021 | |
Rivista: | ||
Tipologia: | Article (author) | |
Data ahead of print / Data di stampa: | 16-giu-2021 | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/s40487-021-00157-1 | |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Saini and CURIGLIANO 2021.pdf | Publisher's version/PDF | Open Access Visualizza/Apri |